Skip to main content
. 2019 Jan 22;9:3135. doi: 10.3389/fimmu.2018.03135

Figure 2.

Figure 2

Absolute counts of (A) Naïve B cells, (B) CD21low B cells, (C) Marginal Zone-like B cells, and (D) Class-switched B cells in CVID patients with lymphoma upon chemotherapy (CVID-ly) compared to the compared to the control group of CVID patients without lymphoma (CVID-cg) and healthy controls (HC); median and 95% are shown.